Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report

Clin Colorectal Cancer. 2021 Sep 15:S1533-0028(21)00088-8. doi: 10.1016/j.clcc.2021.09.002. Online ahead of print.NO ABSTRACTPMID:34629317 | DOI:10.1016/j.clcc.2021.09.002
Source: Clinical Colorectal Cancer - Category: Cancer & Oncology Authors: Source Type: research